CALIMED
ActiveSummary
CALIMED has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.59M and a net result of €519k. Equity is growing by ~32.7% per year across the filed fiscal years. Its solvency ranks better than 95% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability94▼-3
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €250k at 30 days acceptable
short-term debt: 0.5% and cash: 40.2% of total assets, and 0.6% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
99.4%
Return on assets
20%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-09-2026, 46 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
46 d late
2024
29 d late
2023
9 d late
2022
32 d late
2021
88 d late
2020
178 d late
2019
56 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Accepting this client? The AML file with identity, beneficial owners and sanctions lists.AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Financials · fiscal year 2025, abbreviated schema
Equity
€2.59M▲ 25.1%
2024 · €2.07M
Total assets
€2.60M▲ 14.9%
2024 · €2.26M
Net result
€519k▲ 0.6%
2024 · €517k
Working capital
€2.49M▲ 26.9%
2024 · €1.96M
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€414k▲ 12.9%€779k▲ 88.2%€534k▼ 31.5%€716k▲ 34.0%€711k▼ 0.7%
Net result€291k▲ 28.1%€550k▲ 88.8%€388k▼ 29.5%€517k▲ 33.3%€519k▲ 0.6%
Equity€873k▲ 25.8%€1.35M▲ 54.8%€1.70M▲ 26.1%€2.07M▲ 21.2%€2.59M▲ 25.1%
Total assets€2.48M▲ 7.4%€1.42M▼ 43.0%€1.77M▲ 24.8%€2.26M▲ 28.1%€2.60M▲ 14.9%
Debt€1.61M▼ 0.5%€63k▼ 96.1%€62k▼ 2.4%€198k▲ 220%€14k▼ 92.7%
Working capital€624k▲ 14.8%€1.24M▲ 99.3%€1.61M▲ 29.4%€1.96M▲ 22.0%€2.49M▲ 26.9%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.60M
Fixed assets
€95k ▼ 8.0%
Current assets
€2.51M ▲ 15.9%
Equity and liabilities €2.60M
Equity
€2.59M ▲ 25.1%
Debt
€14k ▼ 92.7%
Debt's share of the balance-sheet total falls from 8.7% to 0.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€730k▲
2024 · €729k
Cash flow
€539k▲
2024 · €530k
Debt to equity
0.01▼
2024 · 0.10
ROE
20.1%▼
2024 · 25.0%
ROA
20.0%▼
2024 · 22.8%
Interest coverage
74.35▼
2024 · 1349.08
Debt ≤ 1 year
€14k▼
2024 · €197k
Income taxes
€229k▼
2024 · €232k
A ratio outside any meaningful range has been withheld (balance sheet total €2.60M, equity €2.59M).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €231k | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €27k | €15k | €14k | €14k | €19k | ▲ 40.9% |
| Other operating charges640/8 | €4k | €2k | €2k | €5k | €2k | ▼ 66.1% |
| Gross operating margin9900 | €445k | €797k | €550k | €734k | €732k | ▼ 0.4% |
| Operating profit (loss)9901 | €414k | €779k | €534k | €716k | €711k | ▼ 0.7% |
| Financial income75/76B | €18k | €24k | €23k | €33k | €48k | ▲ 43.4% |
| Recurring financial income75 | €18k | €24k | €23k | €33k | €48k | ▲ 43.4% |
| Financial charges65/66B | €9k | €4k | €-2k | €540 | €10k | ▲ 1,716% |
| Recurring financial charges65 | €9k | €4k | €-2k | €540 | €10k | ▲ 1,716% |
| Profit (loss) for the period before taxes9903 | €423k | €800k | €558k | €748k | €749k | = |
| Income taxes67/77 | €132k | €251k | €171k | €232k | €229k | ▼ 1.1% |
| Profit (loss) for the period9904 | €291k | €550k | €388k | €517k | €519k | ▲ 0.6% |
| Profit (loss) for the period to be appropriated9905 | €291k | €550k | €388k | €517k | €519k | ▲ 0.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.48M | €1.42M | €1.77M | €2.26M | €2.60M | ▲ 14.9% |
| Fixed assets21/28 | €265k | €110k | €96k | €103k | €95k | ▼ 8.0% |
| Tangible fixed assets22/27 | €265k | €110k | €96k | €103k | €95k | ▼ 8.0% |
| Land and buildings22 | €249k | €99k | €89k | €81k | €78k | ▼ 3.7% |
| Plant, machinery and equipment23 | - | - | €504 | €1k | €808 | ▼ 40.6% |
| Furniture and vehicles24 | €16k | €11k | €6k | €20k | €15k | ▼ 22.9% |
| Current assets29/58 | €2.22M | €1.31M | €1.67M | €2.16M | €2.51M | ▲ 15.9% |
| Amounts receivable within one year40/41 | €294k | €145k | €134k | €132k | €5k | ▼ 96.5% |
| Trade receivables40 | - | €758 | - | - | - | - |
| Other amounts receivable41 | €294k | €144k | €134k | €132k | €5k | ▼ 96.5% |
| Current investments50/53 | €361k | €660k | €873k | €725k | €1.14M | ▲ 57.2% |
| Cash at bank and in hand54/58 | €1.29M | €204k | €385k | €963k | €1.04M | ▲ 8.5% |
| Deferred charges and accrued income490/1 | €274k | €296k | €278k | €341k | €316k | ▼ 7.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.48M | €1.42M | €1.77M | €2.26M | €2.60M | ▲ 14.9% |
| Equity10/15 | €873k | €1.35M | €1.70M | €2.07M | €2.59M | ▲ 25.1% |
| Contributions10/11 | €6k | €6k | €6k | €6k | €6k | = |
| Reserves13 | €867k | €1.35M | €1.70M | €2.06M | €2.58M | ▲ 25.2% |
| Non-distributable reserves130/1 | €2k | €2k | - | - | - | - |
| Reserves not available under the articles1311 | €2k | €2k | - | - | - | - |
| Distributable reserves133 | €865k | €1.34M | €1.70M | €2.06M | €2.58M | ▲ 25.2% |
| Amounts payable17/49 | €1.61M | €63k | €62k | €198k | €14k | ▼ 92.7% |
| Amounts payable after more than one year17 | €16k | €350 | - | - | - | - |
| Financial debts170/4 | €14k | - | - | - | - | - |
| Other amounts payable178/9 | €2k | €350 | - | - | - | - |
| Amounts payable within one year42/48 | €1.59M | €61k | €61k | €197k | €14k | ▼ 93.0% |
| Current portion of amounts payable after more than one year42 | €14k | €14k | - | - | - | - |
| Trade debts44 | €3k | €272 | €3k | €8k | €5k | ▼ 32.7% |
| Suppliers440/4 | €3k | €272 | €3k | €8k | €5k | ▼ 32.7% |
| Taxes, remuneration and social security45 | €43k | €47k | €58k | €41k | €9k | ▼ 79.1% |
| Taxes450/3 | €43k | €47k | €47k | €31k | €9k | ▼ 71.7% |
| Remuneration and social security454/9 | - | - | €11k | €11k | - | - |
| Other amounts payable47/48 | €1.53M | - | - | €148k | - | - |
| Accrued charges and deferred income492/3 | - | €1k | €1k | €671 | €693 | ▲ 3.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €291k | €550k | €388k | €517k | €519k | ▲ 0.6% |
| + Depreciation and write-downs630 | €27k | €15k | €14k | €14k | €19k | ▲ 40.9% |
| Operating cash flow (approximation) | €318k | €564k | €402k | €530k | €539k | ▲ 1.6% |
| Investment in fixed assets (approximation) | - | €140k | €-539 | €-20k | €-11k | ▲ 44.8% |
| Change in cash | - | €-1.08M | €181k | €577k | €82k | ▼ 85.8% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 46 days late
2025
31-12
Financial
Liquidity times 17current ratio 182.13
Current ratio from 10.97 to 182.13; short-term debt falls from €197k to €14k.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
31-12
Financial
Equity above €2MEq €2.07M ▲21.2%
7 profitable years in a row build equity to €2.07M.
09-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 9 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
31-12
Financial
Highest result since 2018net €550k ▲88.8%
Operating result €779k, net result €550k, both a record.
31-12
Financial
Liquidity times 15current ratio 21.24
Current ratio from 1.39 to 21.24; short-term debt falls from €1.59M to €61k.
31-12
Financial
Equity above €1MEq €1.35M ▲54.8%
5 profitable years in a row build equity to €1.35M.
27-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 88 days late
25-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 178 days late
2020
31-12
Financial
Equity above €500kEq €695k ▲48.6%
3 profitable years in a row build equity to €695k.
Show earlier events
25-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 56 days late
2019
31-12
Financial
Weakest financial yearnet €85k ▼45.3%
Net result drops to €85k, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
18-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
06-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2008
Ground area
1,477 m²
Building footprint
235 m²
Volume, LiDAR
1,615 m³
Parcel 44038A0705/00K000, Flanders · tallest building 11.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Zandloperstraat 159, 9030 Gent
since 20082.213.803.284
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44038A0705/00K000 | Flanders | 1,477 m² | 1 · 235 m² | 11.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DOKTER DIDIER FONCK
BE 0453.605.949
Ronse · Eq €2,585,809
Medische Centra Cesar de Paepe
BE 0410.684.241
Aarschot · Eq €2,584,035
Dokter Laurence Trappeniers, Medische Beeldvorming
BE 0886.515.662
Sint-Martens-Latem · Eq €2,583,674
COYS GENK
BE 0816.559.064
Genk · Eq €2,578,429
DR. PETER DRIESEN
BE 0472.990.608
Vosselaar · Eq €2,593,086
Of 16,630 companies in sector 86220 we hold annual accounts for 7,981. 4,036 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded14-08-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.